Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.82 CAD | -5.12% | -7.66% | -10.58% |
May. 15 | VBI Vaccines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Earnings Flash (VBIV) VBI VACCINES Reports Q1 Revenue $1.2M | MT |
Sales 2024 * | 12.84M 17.62M | Sales 2025 * | 34.12M 46.8M | Capitalization | 18.36M 25.18M |
---|---|---|---|---|---|
Net income 2024 * | -42M -57.6M | Net income 2025 * | -14M -19.2M | EV / Sales 2024 * | 1.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.54 x |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
-2.29
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
1 day | -5.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 15-07-08 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-05-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 23-04-23 |
Steven Gillis
CHM | Chairman | 71 | 04-12-31 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.69% | 58.71B | |
-2.82% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.60% | 26.55B | |
-22.60% | 18.98B | |
+1.89% | 12.51B | |
+26.48% | 12.08B | |
+21.82% | 11.94B |
- Stock Market
- Equities
- VBIV Stock
- VBV Stock